Articles tagged with Endocrinology
A meta-analysis of 21 studies involving over 178,000 women found that those with infertility history have a 14% increased risk of heart or blood vessel conditions, as well as higher risks of heart disease and stroke. Younger women and those undergoing fertility treatments are at greater risk.
Research found that boys born to mothers with polycystic ovary syndrome (PCOS) or higher testosterone levels during pregnancy are less physically active at age 7. Girls exposed to similar levels of testosterone had lower muscle strength, highlighting the role of maternal testosterone and PCOS in future development.
Research found that early-life growth plays a significant role in determining final adult height, accounting for about 67% of the variation. Childhood growth also accounted for a substantial proportion of the difference in adult height.
Research reveals individuals taking oral steroids for over 3 months are 6 times more likely to be diagnosed with adrenal insufficiency than those treated with non-steroidal anti-inflammatory drugs. Long-term users of inhaled steroids also face increased risk without hospitalisations.
Research suggests that antibiotics taken during infancy, especially in the first three months, may lead to earlier onset of puberty in girls. The study, which analyzed data on over 322,000 children in South Korea, found a significant association between early antibiotic exposure and increased risk of central precocious puberty.
The event aims to create a positive scientific and policy legacy from the Congress in Denmark, Europe, and internationally. The conference will focus on key research presented at the Joint Congress and future priorities from the EndoCompass Research Roadmap.
The IOF Advanced Course on Osteoporosis is a comprehensive, 18-hour online training programme designed to equip healthcare professionals with the latest knowledge in osteoporosis prevention, diagnosis, and management. The course aims to promote timely diagnosis and treatment, reduce patient burden, and improve global outcomes.
The European Society of Endocrinology and the European Hormone and Metabolism Foundation launch a global campaign to raise awareness about hormone balance and its impact on chronic diseases. Small steps can make a big difference in improving hormone health.
Yoshitomo Hoshino, a physician-scientist at The University of Tokyo Hospital, has been recognized with the C. Wayne Bardin, M.D., International Travel Award for his work on autoimmune osteomalacia and bone mineral metabolism.
The Endocrine Society has appointed Manuel Tena-Sempere as the next Editor-in-Chief of its flagship journal Endocrinology. He brings innovative ideas and expertise in neuroendocrinology to further high-quality basic research papers. Tena-Sempere's vision aims to promote rigorous research and scientific collaboration.
Twelve young researchers from around the world receive ESCEO-IOF Young Investigator Awards for their groundbreaking studies on osteoporosis. The prestigious awards were presented during the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2025) in Rome, Italy.
Dr. Elizabeth M. Curtis has been awarded the ESCEO-IOF Pierre Meunier Young Scientist Award for her groundbreaking research on musculoskeletal health and bone disease. Her work focuses on the epidemiology of bone, muscle health, and joint health across the lifespan.
Professor Atsushi Suzuki, Chair of Endocrinology at Fujita Health University School of Medicine, Japan, received the IOF President's Award for his exceptional contributions to IOF. He has shared his expertise as a mentor and engaged member of the Capture the Fracture Governance.
Dr Ambrish Mithal, an Indian endocrinologist, has been awarded the prestigious IOF CSA Medal of Achievement for his groundbreaking work in advancing the field of osteoporosis. His pioneering efforts have significantly increased understanding and awareness of osteoporosis globally.
AMMOM has been recognized by the IOF for its significant contributions to osteoporosis awareness and bone health in Mexico. The organization has collaborated extensively with the IOF on various initiatives, including joint scientific meetings and advocacy efforts.
The Endocrine Society strongly disagrees with the administration's decision not to finalize a rule allowing Medicare and Medicaid to cover anti-obesity medications. This decision leaves millions of Americans with obesity without access to evidence-based treatment, exacerbating the country's growing obesity epidemic.
A new consensus paper emphasizes the role of bone turnover markers (BTMs) in diagnosing and managing osteoporosis. BTMs, such as procollagen type I N propeptide (PINP) and β-isomerized C-terminal telopeptide of type I collagen (β-CTX-I), are invaluable tools for predicting fracture risk and monitoring treatment adherence.
A new clinical trial found that oral semaglutide can significantly reduce cardiovascular events in people with type 2 diabetes and pre-existing cardiovascular disease. The medication decreased the risk of major cardiac events by 14% compared to placebo, with nonfatal myocardial infarction seeing the greatest reductions in risk.
The Endocrine Society expresses concern over the administration's plan to reorganize HHS, slashing federal funding and staff, which will hinder medical discoveries and approve new treatments. The society warns that politicization of scientific grants will harm millions of people needing medical care for endocrine conditions.
A new study reveals a cell atlas of the endometrium in women with PCOS, showing distinct differences in cellular composition and gene expression. The findings suggest that targeting specific cell types may lead to better treatment options for women with PCOS and related reproductive issues.
Media professionals can register for ENDO 2025 to discuss groundbreaking research on obesity, diabetes, and more with world-renowned experts. The event features nearly 2,500 abstracts and over 200 sessions, offering a premier global conference in endocrinology research and clinical care.
Nanette Santoro will become president in June 2026, succeeding an unmentioned prior president. She has held various roles within the Endocrine Society and is a recognized expert in women's reproductive health and menopause research.
Sun Lee, MD, MSc, receives AACE's Rising Star in Endocrinology Award for outstanding leadership and innovative research on thyroid disorders and iodine nutrition. The award honors physicians who demonstrate actionable outcomes in patient care, scientific endeavor, and education.
A new study reviews hormones with anti-aging properties that may be used to prevent skin aging. Hormones such as melatonin, insulin-like growth factor 1, and growth hormone show promising effects on skin function and hair aging.
A new review reveals AI's potential to predict diabetes subtypes, identify high-risk patients, and tailor solutions to individual needs. AI tools can detect early signs of eye damage from diabetes as accurately as specialists, improving accuracy and reducing healthcare costs.
A new study published in JSCAI reveals a lower risk of cardiovascular events for people with Type 1 diabetes, compared to those with Type 2 diabetes. The research highlights the importance of distinguishing between the two types of diabetes and developing targeted treatment strategies.
Donald Patrick McDonnell, a professor at Duke University School of Medicine, has been awarded the Endocrine Society's John D. Baxter Prize for his research on hormone therapies for treating breast and prostate cancers. His work led to the discovery of novel treatments for these cancers and has improved patient care.
A study published in JAMA Network Open found that young adults with Type 2 diabetes and low income have a significantly higher mortality risk compared to those with high income. The research team analyzed over 600,000 patients and found that patients under 40 with low income had a 2.88 times higher mortality risk.
A new study found that yo-yo dieting significantly increases the risk of kidney disease in people with type 1 diabetes. Participants who experienced greater weight fluctuations had a 40% decline in estimated glomerular filtration rate and were more likely to exhibit increased albuminuria.
Professor Ashley Grossman has received the prestigious 2025 Transatlantic Alliance Award for his groundbreaking work on neuroendocrine tumors and pituitary disorders. He is recognized for fostering relationships between endocrinologists in Europe and the US, promoting collaborative efforts that advance global endocrine research.
A new pilot study sheds light on the numerous barriers to effective osteoporosis management, revealing profound knowledge gaps and misinformation. Key findings highlight the need for clear education and trust-building in osteoporosis care.
The European Society of Endocrinology (ESE) and ESE Foundation will host the first-ever World Hormone Day on April 24, 2025. The campaign aims to raise public awareness of good hormone health and improve national political engagement for better prevention, diagnosis, and treatment of endocrine disease.
Researchers analyzed individual cells from two craniopharyngioma subtypes to identify specific cell types, their features, and interactions. The study found distinct cell types linked to tumor development and immune response in both adamantinomatous and papillary craniopharyngiomas.
A new animal study published in the Journal of the Endocrine Society found that early life exposure to polychlorinated biphenyls (PCBs) may lead to behavioral problems in rats. PCBs, which have been banned for decades, can reprogram a developing neuroendocrine system and cause developmental and hormonal changes.
Dr. Seymour Reichlin's centennial celebration highlights his ongoing scientific impact, with recent collaborations yielding new insights into hormone therapies for cognitive enhancement and emotional homeostasis. His work has established neuroendocrinology as a distinct field, bridging neuroscience, endocrinology, and clinical medicine.
The European Society of Endocrinology (ESE) has published an updated curriculum for endocrinology training, aiming to harmonize training standards across Europe. The new curriculum emphasizes lifelong learning and professional skills, such as communication and leadership, to foster greater collaboration and knowledge exchange.
This special issue of Calcified Tissue International presents a collection of critical reviews and original research articles on osteogenesis imperfecta (OI), covering essential aspects of the condition, including its nosology, genetics, and clinical presentation. The contributions also discuss treatment strategies for both children an...
Long-term hormone therapy in transgender individuals leads to significant changes in body composition and risk factors for cardiovascular disease. Transgender men experience increased muscle volume and abdominal fat, while women's muscle mass decreases, according to a new study published in the Journal of Internal Medicine.
A recent study found that levothyroxine use is associated with greater loss of total body bone mass and density, even in participants with normal TSH levels. The research suggests that adults taking levothyroxine should discuss their treatment with their healthcare provider and regularly monitor their thyroid function tests.
New research reveals that hormone therapy can alter skeletal size and shape in transgender individuals who previously suppressed puberty. Transgender men treated with puberty blockers and hormone therapy have broader shoulders and a smaller pelvic inlet, while women have a larger pelvis after treatment from early puberty.
Research found that prolonged blue light exposure accelerates bone growth and bone age, leading to early puberty in rats. This could have implications for children's height and skeletal development in adulthood.
A recent study found that vitamin D supplementation can decrease blood pressure in older adults with obesity and those with low vitamin D levels. High doses of vitamin D did not provide additional health benefits compared to the recommended daily dose.
The editorial highlights how digital tools improve patient outcomes through better monitoring, individualized care, and seamless communication between patients and healthcare providers. Digital health innovations also address key challenges such as data privacy and accessibility.
The Endocrine Society's Virtual Science Writers Conference on Nov. 14 will discuss compounded versions of anti-obesity medications. The event highlights the need for FDA-approved medications to treat obesity, a pressing health concern.
Dr. Reichlin's groundbreaking work on brain-hormone interactions and his influence on generations of endocrinologists are being celebrated through a Festschrift series in Brain Medicine. The series explores multiple facets of his contributions, including pioneering work on hypothalamic control of pituitary function and early recognitio...
The International Osteoporosis Foundation's Capture the Fracture campaign highlights top-performing Fracture Liaison Services that deliver gold-standard care. These services prioritize continuous care, tailored treatment plans, and teamwork to reduce secondary fractures and improve patient outcomes.
A recent study published in the Journal of the Endocrine Society found that high-intensity exercise significantly suppressed ghrelin levels and reduced feelings of hunger in healthy adults. Women demonstrated greater sensitivity to this response compared to men, suggesting sex-specific differences in appetite regulation.
The Endocrine Society's new statement highlights research gaps on opioids' effects on the endocrine system, which can lead to conditions like male hypogonadism and secondary adrenal insufficiency. Clinicians need to monitor patients using opioids for signs of these health consequences.
A low-carbohydrate diet may improve beta-cell function in people with type 2 diabetes, allowing them to better manage their disease and possibly discontinue medication. The study found that participants on a low-carb diet showed significant improvements in acute and maximal beta-cell responses compared to those on a high-carb diet.
The study reveals hormone-dependent molecular mechanisms that cause sexual dimorphism in chicken feathers, including the role of thyroid hormone activation/inactivation system. The findings also shed light on the cultural significance of chickens in Japanese society and its impact on promoting social cohesion.
A new study found that HDL particle quality declines over time in women after menopause, increasing risk of episodic memory loss. Women with smaller, more functional HDL particles are less likely to experience cognitive decline.
Regular moderate coffee or caffeine intake is associated with a lower risk of new-onset cardiometabolic multimorbidity. The study found that moderate consumption could play an important protective role in almost all phases of CM development.
Research suggests that exposure to musk ambrette and cholinergic agonists can trigger early female puberty by activating key hormone receptors. This study highlights the importance of regulating personal care products and environmental chemicals to mitigate potential health risks.
Research published in The Journal of Clinical Endocrinology & Metabolism found that pregnant women with higher levels of PFAS during pregnancy were more likely to experience obesity and heart health issues later in life. Women with lower PFAS levels had healthier cardiometabolic outcomes at age 50.
A team of researchers, led by Jason Shoemaker, are studying the effects of hormones on the immune system's response to the flu. Their goal is to develop targeted therapies based on a person's sex or hormone levels. The study aims to identify the molecules or pathways that affect the cells and begin to develop personalized treatments.
A systematic review and meta-analysis found elevated risks of specific eating disorders among women with PCOS, including bulimia nervosa and binge eating disorder. The study highlights the importance of screening for eating disorders in this population.
A new position paper argues that single race-agnostic FRAX models would unfairly discriminate against Black, Asian, and Hispanic communities. The authors recommend retention of ethnic and race-specific FRAX models for the US with updated data on fracture and death hazards.
The Tulane University-led COBRE will investigate biological sex and gender differences to improve medical outcomes, focusing on differences in autoimmune diseases, pneumonia infections, and treatment responses. The center aims to develop sex-specific miniaturized models of human tissues and organs to study disease progression.
TaVNS has shown significant effects in various body systems, reducing depression scores and treating conditions such as migraines, anxiety, cognitive disorders, Parkinson’s disease, and cognitive decline. It has also demonstrated benefits for the cardiovascular system by lowering blood pressure and heart rate.
A potential new strategy for reducing diabetes risk associated with antipsychotic medications involves co-administering drugs that block dopamine receptors in the brain alongside those that stop these same receptors in the pancreas. This approach may limit metabolic side effects and improve glucose metabolism.